Skip to main content

Advertisement

Log in

Gastrointestinal Bleeding Due to Gastrointestinal Tract Malignancy: Natural History, Management, and Outcomes

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Gastrointestinal (GI) tumor bleeding can vary from occult bleeding to massive hemorrhage and can be the presenting sign of malignancy.

Aims

Our primary aims were to: (1) characterize the natural history, treatment, and outcomes in patients with GI tumor bleeding and (2) compare and contrast bleeding in upper GI (UGI)/small bowel (SB) and lower GI malignancies.

Methods

Patients with endoscopically confirmed tumor bleeding were identified through search of consecutive electronic medical records: Bleeding was determined by the presence of melena, hematochezia, hematemesis, or fecal occult blood. Comprehensive clinical and management data were abstracted.

Results

A total of 354 patients with GI tumors were identified: 71 had tumor bleeding (42 UGI/SB and 29 colonic). GI bleeding was the initial presenting symptom of malignancy in 55/71 (77%) of patients; 26/71 patients had widely metastatic disease at presentation. Further, 15 of 26 patients with metastatic disease presented with GI bleeding. Visible bleeding was present in 14/42 (33%) and 4/29 (14%) of UGI/SB and colonic tumors, respectively. Endoscopic hemostasis was attempted in 10 patients, and although initial control was successful in all, bleeding recurred in all of these patients. The most common endoscopic lesion was clean-based tumor ulceration. Overall mortality at 1 year was 57% for esophageal/gastric, 14% for SB, and 33% for colonic tumors.

Conclusions

When patients with GI malignancy present with GI bleeding, it is often the index symptom. Initial endoscopic hemostasis is often successful, but rebleeding is typical. Esophageal and gastric tumors carry the poorest prognosis, with a high 1-year mortality rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CCI:

Charlson Comorbidity Index

EGD:

Esophagogastroduodenoscopy

GI:

Gastrointestinal

LGI:

Lower GI

SB:

Small bowel

UGI:

Upper GI

References

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:9.

    Article  Google Scholar 

  2. Imbesi JJ, Kurtz RC. A multidisciplinary approach to gastrointestinal bleeding in cancer patients. J Support Oncol. 2005;3:101–110.

    PubMed  Google Scholar 

  3. Cihoric N, Crowe S, Eychmüller S, et al. Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy. Radiat Oncol. 2012;7:7–132.

    Article  Google Scholar 

  4. Strate LL. Lower GI bleeding: epidemiology and diagnosis. Gastroenterol Clin North Am. 2005;34:643–664.

    Article  PubMed  Google Scholar 

  5. Macrae FA, St John DJ. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology. 1982;82:891–898.

    CAS  PubMed  Google Scholar 

  6. Kim YI, Choi IJ. Endoscopic management of tumor bleeding from inoperable gastric cancer. Clin Endosc. 2015;48:121–127.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Allum WH, Brearley S, Wheatley KE, et al. Acute haemorrhage from gastric malignancy. Br J Surg. 1990;77:19–20.

    Article  CAS  PubMed  Google Scholar 

  8. Sheibani S, Kim JJ, Chen B, et al. Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy. Aliment Pharmacol Ther. 2013;38:144–150.

    Article  CAS  PubMed  Google Scholar 

  9. Savides TJ, Jensen DM, Cohen J, et al. Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy. 1996;28:244–248.

    Article  CAS  PubMed  Google Scholar 

  10. Molto A, Dougados M. Comorbidity indices. Clin Exp Rheumatol. 2014;32:131–134.

    Google Scholar 

  11. Eberst ME, Berkowitz LR. Hemostasis in renal disease: pathophysiology and management. Am J Med. 1994;96:168–179.

    Article  CAS  PubMed  Google Scholar 

  12. Guzzo TJ, Dluzniewski P, Orosco R, et al. Prediction of mortality after radical prostatectomy by Charlson Comorbidity Index. Urology. 2010;76:553–557.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Heller SJ, Tokar JL, Nguyen MT, et al. Management of bleeding GI tumors. Gastrointest Endosc. 2010;72:817–824.

    Article  PubMed  Google Scholar 

  14. Wagner AD, Unverzagt S, Grothe W, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010;17:CD004064.

    Google Scholar 

  15. Paoletti X, Oba K, Burzykowski T, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010;303:1729–1737. doi:10.1001/jama.2010.534.

    Article  CAS  PubMed  Google Scholar 

  16. Loftus EV, Alexander GL, Ahlquist DA, et al. Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions. Mayo Clin Proc. 1994;69:736–740.

    Article  CAS  PubMed  Google Scholar 

  17. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394–397.

    Article  CAS  PubMed  Google Scholar 

  18. Kim YI, Choi IJ, Cho SJ, et al. Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer. J Gastroenterol Hepatol. 2013;28:1489–1495.

    Article  PubMed  Google Scholar 

  19. Stapley S, Peters TJ, Sharp D, et al. The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records. Br J Cancer. 2006;95:1321–1325.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Caldarella A, Crocetti E, Messerini L, et al. Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population-based study. Int J Colorectal Dis. 2013;28:637–641.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors’ contributions

RS was involved in study concept and design; acquisition of data; analysis and interpretation of data; drafting of the manuscript; and critical revision of the manuscript for important intellectual content. DR was involved in study concept and design; acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; and study oversight.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Don C. Rockey.

Ethics declarations

Conflict of interest

The authors certify that they have no financial arrangements (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements, research support, honoraria) with a company whose product figures prominently in this manuscript or with a company making a competing product.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schatz, R.A., Rockey, D.C. Gastrointestinal Bleeding Due to Gastrointestinal Tract Malignancy: Natural History, Management, and Outcomes. Dig Dis Sci 62, 491–501 (2017). https://doi.org/10.1007/s10620-016-4368-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4368-y

Keywords

Navigation